Alzheimer; News from the web:
A new approach to treat Alzheimer’s disease, potentially targeting the root cause of memory decline
The ACT-AD and LIFT-AD trials are evaluating if a new investigational drug is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease.
The investigational drug of the ACT-AD and LIFT-AD trials is designed to:
- Boost a repair and regenerative pathway for brain cells
- Promote brain health and function
There may be a trial near you check it out
Read all about it HERE